Response to the letter “Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients”, by C. Allior (Ann. Oncol 2004; 15: 1576–1577)
Titel:
Response to the letter “Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients”, by C. Allior (Ann. Oncol 2004; 15: 1576–1577)
Auteur:
Ducreux, M. Mitry, E. Ould-Kaci, M. Boige, V. Seitz, J.F. Bugat, R. Breau, J.L. Bouché, O. Etienne, P.L. Tigaud, J.M. Morvan, F. Cvitkovic, E. Rougier, P.